Impact of Malaria Control on the Demand for ACTs

Vista sencilla de ítem
dc.creatorLaxminarayan, Ramanan
dc.creatorKlein, Eili
dc.creatorSmith, David
dc.date2013-05-29T14:45:46Z
dc.date2013-05-29T14:45:46Z
dc.date2008-06
dc.date.accessioned2026-07-01T01:21:57Z
dc.descriptionAs planning for malaria shifts from control to elimination and eventual eradication, policymakers are faced with decisions about resource allocation, and best approaches for financing malaria control interventions. At the operational level, these decisions will determine the relative emphasis on different tools such as insecticide treated nets (ITNs), indoor residual spraying (IRS) and artemisinin-based combinations (ACTs) in various local settings. At a global level, these decisions will guide the appropriate role of global financing mechanisms such as the Affordable Medicines Facility for Malaria (AMFm) in the malaria elimination effort. Previous papers have separately examined the cost-effectiveness of individual tools like IRS and ITNs and financing mechanisms such as the AMFm. Here we look at the cost-effectiveness of AMFm at different transmission intensities and levels of malaria control. We find that deaths averted as a result of AMFm are maximized when other control measures such as ITNs are simultaneously applied. Although policymakers have to tradeoff between investments in AMFm and malaria prevention tools, our results indicate strong synergies that get stronger as malaria control is amplified.
dc.formatapplication/pdf
dc.formattext/plain
dc.identifierhttp://documents.worldbank.org/curated/en/2008/06/12327991/impact-malaria-control-demand-artemisinin-based-combinations-acts
dc.identifierhttps://hdl.handle.net/10986/13615
dc.identifierhttps://doi.org/10.1596/13615
dc.identifier.urihttp://hdl.handle.net/123456789/417430
dc.languageEnglish
dc.languageen_US
dc.publisherWorld Bank, Washington, DC
dc.relationHealth, Nutrition and Population (HNP) discussion paper;
dc.rightsCC BY 3.0 IGO
dc.rightshttp://creativecommons.org/licenses/by/3.0/igo/
dc.rightsWorld Bank
dc.subjectALLOCATION OF RESOURCES
dc.subjectANOPHELES
dc.subjectANOPHELES MOSQUITOES
dc.subjectANTIMALARIAL
dc.subjectANTIMALARIAL DRUG
dc.subjectANTIMALARIAL DRUG RESISTANCE
dc.subjectANTIMALARIAL DRUGS
dc.subjectANTIMALARIALS
dc.subjectASEXUAL PARASITES
dc.subjectBACK MALARIA
dc.subjectBED NETS
dc.subjectBLIND
dc.subjectBURDEN OF MALARIA
dc.subjectCASE MANAGEMENT
dc.subjectCHILD DEATHS
dc.subjectCHILD MORTALITY
dc.subjectCHILD SURVIVAL
dc.subjectCLINICAL CASES
dc.subjectCLINICAL MALARIA
dc.subjectCLINICS
dc.subjectCOMBINATION THERAPIES
dc.subjectDEVELOPING COUNTRIES
dc.subjectDIAGNOSTIC TESTS
dc.subjectDISABILITY
dc.subjectDISEASE
dc.subjectDISEASE BURDEN
dc.subjectDISEASE TRANSMISSION
dc.subjectDRUG ADMINISTRATION
dc.subjectDRUG RESISTANCE
dc.subjectDRUG TREATMENT
dc.subjectDRUG USE
dc.subjectEFFECTIVE ANTIMALARIAL DRUGS
dc.subjectENDEMIC COUNTRIES
dc.subjectFALCIPARUM MALARIA
dc.subjectFAMILIES
dc.subjectFEVER
dc.subjectFEVERS
dc.subjectFOREST COVER
dc.subjectGLOBAL DEVELOPMENT
dc.subjectGLOBAL HEALTH
dc.subjectHEALTH POLICY
dc.subjectHIV
dc.subjectHUMAN DEVELOPMENT
dc.subjectIMPACT OF MALARIA
dc.subjectIMPREGNATED BEDNETS
dc.subjectINFECTION
dc.subjectINFECTIONS
dc.subjectINSECTICIDE-TREATED NETS
dc.subjectLARVAL ECOLOGY
dc.subjectMALARIA BURDEN
dc.subjectMALARIA CASES
dc.subjectMALARIA CONTROL
dc.subjectMALARIA CONTROL ACTIVITIES
dc.subjectMALARIA DEATHS
dc.subjectMALARIA DRUGS
dc.subjectMALARIA INCIDENCE
dc.subjectMALARIA MORBIDITY
dc.subjectMALARIA PARASITES
dc.subjectMALARIA PREVENTION
dc.subjectMALARIA TRANSMISSION
dc.subjectMALARIA TREATMENT
dc.subjectMEDICINE
dc.subjectMEFLOQUINE
dc.subjectMORBIDITY AND MORTALITY
dc.subjectMOSQUITO NETS
dc.subjectNEW INFECTIONS
dc.subjectNUMBER OF DEATHS
dc.subjectNUTRITION
dc.subjectPARASITE DEVELOPMENT
dc.subjectPARASITE POPULATION
dc.subjectPARASITEMIA
dc.subjectPARASITES
dc.subjectPARASITOLOGY
dc.subjectPLASMODIUM FALCIPARUM
dc.subjectPOPULATION DYNAMICS
dc.subjectPREGNANCY
dc.subjectPREVALENCE
dc.subjectPREVENTING MALARIA
dc.subjectPREVENTION OF MALARIA
dc.subjectPREVENTIVE TREATMENT
dc.subjectPROGRESS
dc.subjectPUBLIC SECTOR CLINICS
dc.subjectPYRIMETHAMINE
dc.subjectRESIDUAL SPRAYING
dc.subjectRESOURCE ALLOCATION
dc.subjectSEVERE MALARIA
dc.subjectSEVERE MALARIA MORBIDITY
dc.subjectSOCIAL MARKETING
dc.subjectSPECIES
dc.subjectSULFADOXINE
dc.subjectSYMPTOMATIC INFECTIONS
dc.subjectSYMPTOMS
dc.subjectTHERAPIES
dc.subjectTHERAPY
dc.subjectTRANSMISSION INTENSITY
dc.subjectTREATED NETS
dc.subjectTREATMENT
dc.subjectTUBERCULOSIS
dc.subjectVACCINE
dc.subjectVACCINES
dc.subjectVECTOR CONTROL
dc.subjectWORLD HEALTH ORGANIZATION
dc.subjectartemisinin-based combinations
dc.titleImpact of Malaria Control on the Demand for ACTs

Archivos

Colecciones

AgroKnow